Stockscreener 앱 받기
12.96
2.61%
0.33
시간 외 거래:
12.97
0.010
+0.08%
전일 마감가:
$12.63
열려 있는:
$12.64
하루 거래량:
1.44M
Relative Volume:
1.11
시가총액:
$1.01B
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
25.92
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
+5.28%
1개월 성능:
-0.31%
6개월 성능:
-48.61%
1년 성능:
-40.50%
1일 변동 폭
$12.61
$13.16
1주일 범위
$11.96
$13.16
52주 변동 폭
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.96 | 963.76M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Published on: 2025-08-10 02:52:05 - Newser
What’s the recovery path for long term holders of Integra LifeSciences Holdings CorporationShort-Term AI-Based Stock Price Forecast - Newser
Using data models to predict Integra LifeSciences Holdings Corporation stock movementFree Price Action Based Buy Opportunity List - Newser
Is now a turning point for Integra LifeSciences Holdings CorporationFree Triple Digit Return Stock Predictions - Newser
Price action breakdown for Integra LifeSciences Holdings CorporationStock Market Trend and Pattern Analysis - Newser
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionEntry Optimization Guide with Volume Analysis - Newser
Integra LifeSciences Holdings Corporation’s volatility index tracking explainedLong-Term Allocation Strategy Summary Breakdown - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stockSmart Entry Signals for Active Traders - Newser
Top chart patterns to watch in Integra LifeSciences Holdings CorporationGrowth Watchlist for Long Term Positioning - Newser
What makes Integra LifeSciences Holdings Corporation stock price move sharplyBreakout Stock Opportunities with Low Drawdown - Newser
Evaluating Integra LifeSciences Holdings Corporation with trendline analysisTriple Digit Gain Opportunity Watchlist - newser.com
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript - Insider Monkey
Has Integra LifeSciences Holdings Corporation Stock Ever Crashed Historical Volatility ReviewFree Intraday Trend Analysis for Fast Gains - Newser
Integra LifeSciences Holdings Corporation Company’s Quarterly Earnings Growth: What the Numbers SayFree Swing Trading Plan With Smart Signals - Newser
JMP reiterates Market Outperform rating on Integra LifeSciences stock By Investing.com - Investing.com Canada
JMP reiterates Market Outperform rating on Integra LifeSciences stock - Investing.com
KLP Kapitalforvaltning AS Cuts Stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - Norwalk Hour
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Integra LifeSciences Q2 2025 slides: Revenue dips, projects second-half rebound - Investing.com Canada
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M - GuruFocus
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performanc - GuruFocus
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M, Exceeding Estimates; Adjusted EPS at $0.45, Surpassing Expectations - GuruFocus
Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets - Yahoo Finance
Integra Lifesciences Topped Revenue Estimates Despite Investor Caution - Finimize
Integra LifeSciences Reports Second Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performance - GuruFocus
Integra Lifesciences Holdings Corp to Report Q2 2025 Earnings on July 31, 2025 with Expected Revenue of $395.07 Million and Earnings of $0.00 per Share - AInvest
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q2 2025 Result - Yahoo Finance
Allianz Asset Management GmbH Buys 71,939 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo.co
Published on: 2025-07-29 18:17:19 - metal.it
Cwm LLC Boosts Position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Published on: 2025-07-28 21:45:23 - metal.it
Should I hold or sell Integra LifeSciences Holdings Corporation stock in 2025Discover breakthrough investment opportunities - Jammu Links News
What is Integra LifeSciences Holdings Corporation company’s growth strategyGet alerts on the hottest stocks daily - jammulinksnews.com
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsFast Growing Stocks - Newser
Integra LifeSciences Holdings Corporation Company Revenue and Profit Trends: A Deep Dive - Newser
Strong week for Integra LifeSciences Holdings (NASDAQ:IART) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Can Integra LifeSciences Holdings Corporation stock recover from recent declineOutperformance with explosive growth - Jammu Links News
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - uk.finance.yahoo.com
What analysts say about Integra LifeSciences Holdings Corporation stockConsistently exceptional gains - Autocar Professional
What drives Integra LifeSciences Holdings Corporation stock priceUnprecedented profits - Jammu Links News
Bank of New York Mellon Corp Trims Holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Is Integra LifeSciences Holdings (NASDAQ:IART) Using Too Much Debt? - simplywall.st
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):